• Mashup Score: 19

    Gastroenterologists Corey Siegel, MD, David Rubin, MD, and Gil Melmed, MD, along with medical resident Jamie Horrigan, MD, who has Crohn disease, discuss the safety and efficacy of COVID-19 vaccines for patients with inflammatory bowel disease, how to talk to patients about the importance and the risks of vaccines, and the questions that remain to be fully answered.

    Tweet Tweets with this article
    • NEW! Please check out our roundtable about #COVID19Vaccine and #IBD, including comments about whether we might need a booster in the fall, and how to discuss all this with our patients and colleagues. @DrCoreySiegel @GilMelmedMD @jamiehorrigan https://t.co/QMCAKf0z2H

  • Mashup Score: 2

    Dr Raffals, of the Mayo Clinic in Rochester, Minnesota, explains the various types of disorders that patients who have undergone ileal pouch anal anastamosis surgery may present with and how gastroenterologists can ensure these patients receive the care they need.

    Tweet Tweets with this article
    • WATCH: @LauraRaffalsMD explains the various types of disorders that patients who have undergone ileal pouch anal anastamosis #IPAA surgery may present with and how gastroenterologists can ensure these patients receive the care they need. @Gastro_Network https://t.co/5ADLI1v53K

  • Mashup Score: 8

    Clearly communicating the findings of endoscopy to pathologists, colleagues, and patients requires some standardization in the preparation of endoscopic reports, David T. Rubin, MD, told the attendees of the Advances in Inflammatory Bowel Diseases 2020 virtual meeting on December 11.

    Tweet Tweets with this article
    • Nice summary of my @IBDConference lecture on standardizing endoscopic reporting (with a glimpse to the near future and artificial intelligence). https://t.co/3EQJkAGcFX https://t.co/aD9edHFUIk

  • Mashup Score: 7

    Dr Rubin, chief of gastroenterology, hepatology, and nutrition and codirector of the Digestive Diseases Center at UChicago Medicine, provides perspective on how the COVID-19 pandemic has affected medical practice over the past 8 months and what clinicians have learned about the risks for patients with inflammatory bowel disease.

    Tweet Tweets with this article
    • Hear my take on what we've learned about #IBD and #COVID19 (or read the transcript). I cover risks, therapies, telehealth and even vaccines. The latest as of Nov 2020. https://t.co/uZFLq3wlXZ

  • Mashup Score: 3

    In this video, Dr Rubin, from UChicago Medicine, reviews the indicators for when it is possible or even preferable to reduce medications in the treatment of inflammatory bowel disease, which he discussed at the American College of Gastroenterology clinical meeting and postgraduate course.

    Tweet Tweets with this article
    • Brief video summary of my @AmCollegeGastro lecture on de-intensification of therapy in #IBD. Key points: ▶️It's not for everyone! Make sure of deep remission, preferably for >1 year. ▶️Have a monitoring plan! ▶️Decide on a rescue strategy ahead of time. https://t.co/sQq6aKA1yZ